LU85854A1 - Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1,2,4-triazole-3-carboxamide - Google Patents

Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1,2,4-triazole-3-carboxamide Download PDF

Info

Publication number
LU85854A1
LU85854A1 LU85854A LU85854A LU85854A1 LU 85854 A1 LU85854 A1 LU 85854A1 LU 85854 A LU85854 A LU 85854A LU 85854 A LU85854 A LU 85854A LU 85854 A1 LU85854 A1 LU 85854A1
Authority
LU
Luxembourg
Prior art keywords
compound
viral diseases
caused
composition
medical treatment
Prior art date
Application number
LU85854A
Other languages
English (en)
French (fr)
Inventor
Roberts Angus Smith
Humberto Fernandez
Original Assignee
Vira Tek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24673430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU85854(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vira Tek Inc filed Critical Vira Tek Inc
Publication of LU85854A1 publication Critical patent/LU85854A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LU85854A 1984-10-29 1985-04-17 Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1,2,4-triazole-3-carboxamide LU85854A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66625284A 1984-10-29 1984-10-29
US66625284 1984-10-29

Publications (1)

Publication Number Publication Date
LU85854A1 true LU85854A1 (fr) 1985-12-16

Family

ID=24673430

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85854A LU85854A1 (fr) 1984-10-29 1985-04-17 Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1,2,4-triazole-3-carboxamide

Country Status (19)

Country Link
EP (3) EP0643970B1 (de)
JP (1) JPH0713019B2 (de)
KR (1) KR860003018A (de)
AT (1) ATE204173T1 (de)
AU (1) AU584333B2 (de)
BE (1) BE902199A (de)
CA (1) CA1261265A (de)
DD (1) DD261094A5 (de)
DE (3) DE3588232T2 (de)
ES (1) ES8704962A1 (de)
FR (1) FR2572286B1 (de)
GB (1) GB2166050B (de)
HK (1) HK1010985A1 (de)
LU (1) LU85854A1 (de)
NL (1) NL300083I1 (de)
NZ (1) NZ212510A (de)
PH (1) PH22534A (de)
PT (1) PT81387B (de)
ZA (1) ZA858237B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650377T2 (de) * 1985-12-23 1996-02-22 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
JP2792246B2 (ja) * 1991-01-31 1998-09-03 信越半導体株式会社 単結晶棒クランプ位置決め治具及びこれを用いた単結晶棒クランプ位置決め方法
HUP0200027A2 (en) * 1999-01-29 2002-04-29 Icn Pharmaceuticals Modulation of immune response by ribavirin
US6720000B2 (en) 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
US7132453B2 (en) * 2002-03-15 2006-11-07 Vanderbilt University Method of using prostacyclin to treat respiratory syncytial virus infections
US7538094B2 (en) 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
EP2959901A1 (de) 2014-06-23 2015-12-30 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmazeutische kombinationen aus sofosbuvir und ribavirin
WO2015197535A1 (en) 2014-06-23 2015-12-30 Sanovel Ilac Sanayi Ve Ticaret A.S. Modified release pharmaceutical compositions of sofosbuvir and ribavirin
EA201692515A1 (ru) 2014-06-23 2017-05-31 Сановель Илач Санайи Ве Тиджарет А.Ш. Новая фармацевтическая композиция на основе софосбувира и рибавирина

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
US3927216A (en) * 1971-06-01 1975-12-16 Icn Pharmaceuticals 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
AR205339A1 (es) * 1973-03-12 1976-04-30 Icn Pharmaceuticals Sintesis de 1,2,4-triazolo-3-carboxamidas utiles como agentes antivirales
WO1983003383A1 (en) * 1982-03-29 1983-10-13 Liposome Co Inc Stable plurilamellar vesicles

Also Published As

Publication number Publication date
AU584333B2 (en) 1989-05-25
NL300083I1 (nl) 2002-05-01
DE3588232D1 (de) 2001-09-20
JPS61109723A (ja) 1986-05-28
PT81387A (en) 1985-11-01
FR2572286A1 (fr) 1986-05-02
EP0643970A3 (de) 1997-07-09
PT81387B (pt) 1987-11-11
GB2166050A (en) 1986-04-30
CA1261265A (en) 1989-09-26
NZ212510A (en) 1989-04-26
JPH0713019B2 (ja) 1995-02-15
DE10299005I2 (de) 2004-07-01
KR860003018A (ko) 1986-05-19
PH22534A (en) 1988-10-17
GB2166050B (en) 1989-08-16
EP0383361A2 (de) 1990-08-22
ES8704962A1 (es) 1987-04-16
FR2572286B1 (fr) 1990-03-23
DE3588232T2 (de) 2002-06-13
DD261094A5 (de) 1988-10-19
HK1010985A1 (en) 1999-07-02
EP0643970A2 (de) 1995-03-22
DE181050T1 (de) 1986-12-18
EP0643970B1 (de) 2001-08-16
GB8509689D0 (en) 1985-05-22
DE10299005I1 (de) 2002-05-08
AU4180785A (en) 1986-05-08
ZA858237B (en) 1988-02-24
EP0181050A3 (de) 1987-10-21
EP0383361A3 (de) 1993-06-16
ATE204173T1 (de) 2001-09-15
EP0181050A2 (de) 1986-05-14
BE902199A (fr) 1985-07-31
ES548303A0 (es) 1987-04-16

Similar Documents

Publication Publication Date Title
EP3528835B1 (de) Antivirale zusammensetzungen zur behandlung von infektionen im zusammenhang mit coronaviren
EP0352147A2 (de) Verwendung von Naringin, Naringenin oder ihrer Derivate zur Herstellung eines Antikrebsmittels
LU85854A1 (fr) Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1,2,4-triazole-3-carboxamide
Korba et al. Liver-targeted antiviral nucleosides: Enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infectionin vivo
JP2899292B2 (ja) Ｂ型肝炎の抗ウイルス剤による治療方法
CA2286126C (en) Pharmaceutical compositions
WO2021181044A1 (fr) Composition comprenant du diltiazem pour traiter l'infection virale par les virus sars-cov-2
Child et al. Canadian multicenter azidothymidine trial: AZT pharmacokinetics
JPH02501220A (ja) 芳香族多環式ジオンを含有する抗ウイルス性薬剤及びレトロウイルス感染治療方法
JPH10504279A (ja) ウイルス感染症及び場合により炎症の予防及び／又は治療用医薬組成物並びにそれらの治療方法
FR2620130A1 (fr) Nouveaux polysaccharides hydrosolubles, leur procede d'obtention, leur application a titre de medicaments et preparation les renfermant
WO2018178594A1 (fr) Prévention d'une infection par le virus respiratoire syncytial dans les voies respiratoires supérieures
EP0082667A1 (de) Pharmazeutische Zusammensetzungen
JP2000516962A (ja) ライノウイルス感染症の治療方法
EP0362359A1 (de) Antiviren-zubereitung, enthaltend aromatische polycyclische dione und nukleosidanaloge und verfahren zur behandlung von retrovireninfektionen
FR3136962A1 (fr) Vaccin contre le coronavirus
CA3207366A1 (fr) Composition therapeutique a base de feuilles de neurolaena inhibitrice de la dhodh pour le traitement d'infections par virus a arn
WO1989009055A1 (en) Antiviral composition containing aromatic polycyclic diones and nucleoside analogs and method for treating retrovirus infections
EP0004214A1 (de) Pharmazeutische Präparate enthaltend ein bakterielles Enzym
JPH02504283A (ja) 芳香族多環式ジオン化合物とヌクレオシド類似化合物とを含む抗ウイルス性組成物及びレトロウイルス感染を治療するための方法
MXPA01009076A (en) Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
JP2002511862A (ja) ウイルス性および微生物性感染ならびに消耗性症候群の治療に用いる薬剤供給装置および方法
MXPA99008690A (en) Pharmaceutical compositions
WO2001080848A1 (fr) Compositions destinees a inhiber la proliferation du virus d'immunodeficience humaine et methode d'inhibition de la proliferation de ce virus